US gene therapy trials for a rare immune disorder, suspended after a patient in a similar French trial developed a leukaemia-like disease, should now go ahead, says the Recombinant DNA Advisory Committee (RAC). In October, gene therapy trials for severe combined immunodeficiency (SCID) were halted in several countries, after scientists...
Paul Fielding, the British embryologist accused of assault, deception, false accounting and offences under the Human Fertilisation and Embryology Act 1990, was convicted last week following his trial at Southampton Crown Court. Fielding, who worked as an embryologist at two clinics in Hampshire, was accused of pretending to thaw stored...
A woman has called for a change to the law, after embryos that she created during IVF treatment with her former husband were destroyed without her knowledge or consent. She is supported in her campaign by her MP, David Stewart, who will now fight for changes to be made to...
The UK's Department of Trade and Industry has announced an increase of funding for embryonic stem cell research. Newspapers have claimed that this will make Britain the world's leading public funder of stem cell research. Forty million pounds will be disbursed over the next three years, for basic research into...
Stanford University in California, US, has announced that it intends to clone human embryos in order to produce embryonic stem cells for research into disease and injury. This is the first time an American university has publicly endorsed the procedure. The cloning work will be part of a new Institute...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
Comment
Good and bad news in IVF
by Juliet Tizzard
This week's BioNews reports on the trial of Paul Fielding, the British embryologist who has been found guilty of deceiving IVF patients over their frozen embryos. It's an unfortunate development that comes at the end of a difficult year in which bad news stories have been a feature of the...